GSK to produce 1 billion doses of coronavirus vaccine booster in 2021
Updated : May 28, 2020 12:38 PM IST
The London-listed company said it was in talks with governments on backing for the programme, which would effectively allow for a scaling up of production of future successful vaccines for the disease caused by the novel coronavirus.
GSK is one of several companies in the race to develop a vaccine for the respiratory illness that currently has no treatment and has already killed about 350,000 people.
The British drugmaker is working on its own COVID vaccine with Sanofi.